Calcimedica (CALC)Director bought ~$200K
Fred A Middleton, Director at Calcimedica, bought ~$200K of Calcimedica shares.
- ~$200K
- Approx. value · 249K sh @ $0.8033
- 1.06M
- Holds after · shares reported
- Traded
- Jun 25, 2026
- Filed
- Jun 29, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 12, 2026Company filing · Form 8-K · ResultsReported its results
- Jun 23, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 2 more items)
- Jun 23, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
- Jun 25, 2026 · this disclosureInsider · 7 days before an 8-KDirector purchased ~$200K of CALC shares in the open market
What came next
- Jul 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 2, 2026, the board of directors (the “Board”) of CalciMedica, Inc., a Delaware corporation (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), increased the size of the Board from seven directors to eight directors.”
- Aug 11, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 19, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On August 19, 2026, CalciMedica, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”
- Aug 27, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Calcimedica
OQRO holds no insider, Congress, fund or contract record for Calcimedica dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CALC page.
Other recent filings by Fred A Middleton, Director
- SEC Form 4 at Calcimedica (CALC)Dec 7, 2024
- SEC Form 4 at Calcimedica (CALC)Nov 5, 2024
- SEC Form 4 at Calcimedica (CALC)Nov 5, 2024
- SEC Form 4 at Calcimedica (CALC)Nov 5, 2024
The full history of Fred A Middleton, Director is on the profile page.
How this filing works
Other disclosures at Calcimedica
- SEC Form 4Sep 22, 2025
- SEC Form 4Sep 17, 2025
- SEC Form 4Sep 15, 2025
- SEC Form 4Sep 11, 2025
- SEC Form 4Sep 2, 2025
- SEC Form 4Sep 2, 2025
Everything OQRO holds on this company is on its CALC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
